News Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/06/2024 am IST			5-day change	1st Jan Change
2,000 ^KRW	-1.48%		-4.76%	-40.83%

16/05	Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
21/03	Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Eutilex.Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Eutilex.Co.,Ltd(KOSDAQ:A263050) dropped from S&P Global BMI Index	18/23/18	CI
Eutilex.Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Eutilex.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/23/23	CI
Eutilex.Co.,Ltd. announced that it has received KRW 22.5003376 billion in funding	20/21/20	CI
Eutilex.Co.,Ltd. announced that it expects to receive KRW 22.5003376 billion in funding	12/21/12	CI
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA	27/21/27	CI
Eutilex.Co.,Ltd. announced that it has received KRW 19.9998552 billion in funding from SUSUNG ASSET MANAGEMENT Co., Ltd., Asset One	30/20/30	CI
Eutilex.Co.,Ltd. announced that it expects to receive KRW 19.9998552 billion in funding from SUSUNG ASSET MANAGEMENT Co., Ltd., Asset One	22/20/22	CI
Eutilex Co.,Ltd. announced that it has received KRW 29 billion in funding	04/20/04	CI
Eutilex Co.,Ltd. announced that it expects to receive KRW 29 billion in funding	24/20/24	CI
CDMO business GenScript ProBio and Eutilex Co., Ltd. Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for Car-T Programs	07/20/07	CI
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24/19/24	CI
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24/19/24	CI
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24/19/24	CI
Eutilex Co.,Ltd. has completed an IPO in the amount of KRW 36.35 billion.	19/18/19	CI
Eutilex Co.,Ltd. has filed an IPO.	18/18/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Eutilex.Co.,Ltd

Equities

A263050

KR7263050007

Summary

Filters